Shell Asset Management’s Lyell Immunopharma LYEL Stock Holding History

Shell Asset Management’s Portfolio LYEL Stock Details LYEL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-320	Closed	-$3K	–	1222
2025 Q2	$3K	Hold	320	–	–	﹤0.01%	1264
2025 Q1	$3K	Sell	320 -321	-50%	-$3.93K	﹤0.01%	1257
2024 Q4	$8K	Sell	641 -5,758	-90%	-$114K	﹤0.01%	1254
2024 Q3	$177K	Buy	+6,399	New	+$188K	0.01%	880
2024 Q1	$190K	Sell	6,536 -664	-9%	-$28.4K	0.01%	841
2023 Q4	$279K	Sell	7,200 -2,158	-23%	-$77.7K	0.01%	734
2023 Q3	$275K	Sell	9,358 -162	-2%	-$7.69K	0.01%	791
2023 Q2	$605K	Buy	+9,520	New	+$527K	0.02%	509

Other funds holding LYEL

Arch Venture Management Chicago, Illinois $677M AUM 322.07% 1-Year Est. Return

MWG Management Road Town, Tortola, British Virgin Islands $81.3M AUM 2.28% 1-Year Est. Return

Foresite Capital Management IV Larkspur, California $237M AUM 107.53% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Orland Properties Ltd Road Town, Tortola, British Virgin Islands $267M AUM 5.05% 1-Year Est. Return

Decheng Capital Menlo Park, California $661M AUM 299.97% 1-Year Est. Return

Almitas Capital Santa Monica, California $443M AUM 42.36% 1-Year Est. Return

Foresite Capital Management V Larkspur, California $271M AUM 309.87% 1-Year Est. Return

venBio Partners San Francisco, California $281M AUM 261.03% 1-Year Est. Return

Citadel Advisors

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return